SA
GILD icon

swisspartners Advisors’s Gilead Sciences GILD Stock Holding History

swisspartners Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-60,160
Closed -$3.91M – 21
2019
Q4 		$3.91M Buy
+60,160
New +$3.92M 3.83% 12

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

swisspartners Advisors's GILD Position: Q1 2020 in Review

swisspartners Advisors sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 60,160 shares — an estimated $3.91M sold.

swisspartners Advisors first reported a position in GILD in Q4 2019 and held it in 1 quarter. The position peaked at $3.91M in Q4 2019. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • swisspartners Advisors reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • swisspartners Advisors sold 60,160 Gilead Sciences shares in Q1 2020, an estimated $3.91M.
  • swisspartners Advisors first reported a position in Gilead Sciences in Q4 2019 and held it in 1 quarter.
  • swisspartners Advisors's Gilead Sciences position peaked at $3.91M in Q4 2019.
  • 1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on swisspartners Advisors's 13F filing for Q1 2020, filed 15 May 2020.